InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
73.89
(
-0.34%
)
Bitcoin
62,922.05
(
-0.72%
)
Post# of 6306
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

BioBull1

Send PM Follow Ignore
Followers 0
Posts 56
Boards Moderated 0
Alias Born 01/11/2016

BioBull1

Re: TheHound post# 5644

Friday, 11/18/2016 9:16:37 AM

Friday, November 18, 2016 9:16:37 AM

Post# of 6306
Hound, the clinical trial site has stated June 2017 for nearly two years, however, it is meaningless as it would require Invivo to enroll 11 eligible patients in the next month in order to assess them all at the six month endpoint.

On another note, I've asked before but never received any feedback; why did the 10-Q's filed by this company suddenly call out INSPIRE as a 30 patient trial? Another fumble of poor communication from the BOD?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up